Similar articles for PMID: 11760972

Year	Number of Results
1987	1
2001	3
2002	4
2003	2
2004	1
2005	4
2006	4
2007	5
2008	10
2009	3
2010	1
2011	1
2012	2
2013	1
2014	1
2015	1
2017	1
2024	0

1

Baseline staging tests in primary breast cancer.

Watine J. Watine J. CMAJ. 2001 Nov 13;165(10):1301. CMAJ. 2001. PMID: 11760972 Free PMC article. No abstract available.

2

Ishioka C. Ishioka C. Gan To Kagaku Ryoho. 2008 Aug;35(8):1261-8. Gan To Kagaku Ryoho. 2008. PMID: 18701834 Review. Japanese.

3

Breast pathology guideline implementation in low- and middle-income countries.

Masood S, Vass L, Ibarra JA Jr, Ljung BM, Stalsberg H, Eniu A, Carlson RW, Anderson BO; Breast Health Global Initiative Pathology Focus Group. Masood S, et al. Cancer. 2008 Oct 15;113(8 Suppl):2297-304. doi: 10.1002/cncr.23833. Cancer. 2008. PMID: 18837021 Free article.

4

[Vascular endothelial growth factor and two types of its receptors in breast cancer].

Shcherbakov AM, Gershteĭn ES, Anurova OA, Kushlinskiĭ NE. Shcherbakov AM, et al. Vopr Onkol. 2005;51(3):317-21. Vopr Onkol. 2005. PMID: 16279095 Russian.

5

Anthracycline war: no victor yet.

Young P. Young P. J Natl Cancer Inst. 2009 Sep 2;101(17):1171-3. doi: 10.1093/jnci/djp303. Epub 2009 Aug 25. J Natl Cancer Inst. 2009. PMID: 19706625 No abstract available.

6

Breast fine needle aspiration biopsy: prevailing recommendations and contemporary practices.

Abati A, Simsir A. Abati A, et al. Clin Lab Med. 2005 Dec;25(4):631-54, v. doi: 10.1016/j.cll.2005.08.003. Clin Lab Med. 2005. PMID: 16308084 Review.

7

Poor-prognosis estrogen receptor-positive breast cancer identified by histopathologic subclassification.

Webster LR, Lee SF, Ringland C, Morey AL, Hanby AM, Morgan G, Byth K, Mote PA, Provan PJ, Ellis IO, Green AR, Lamoury G, Ravdin P, Clarke CL, Ward RL, Balleine RL, Hawkins NJ. Webster LR, et al. Clin Cancer Res. 2008 Oct 15;14(20):6625-33. doi: 10.1158/1078-0432.CCR-08-0701. Clin Cancer Res. 2008. PMID: 18927304 Free article.

8

Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel.

Millar EK, Graham PH, O'Toole SA, McNeil CM, Browne L, Morey AL, Eggleton S, Beretov J, Theocharous C, Capp A, Nasser E, Kearsley JH, Delaney G, Papadatos G, Fox C, Sutherland RL. Millar EK, et al. J Clin Oncol. 2009 Oct 1;27(28):4701-8. doi: 10.1200/JCO.2008.21.7075. Epub 2009 Aug 31. J Clin Oncol. 2009. PMID: 19720911 Clinical Trial.

9

Lack of prognostic significance of nm23 expression in human primary breast cancer.

Göhring UJ, Eustermann I, Becker M, Neuhaus W, Rein DT, Schöndorf T. Göhring UJ, et al. Oncol Rep. 2002 Nov-Dec;9(6):1205-8. Oncol Rep. 2002. PMID: 12375020

10

Possible predictive markers related to micro-metastasis in breast cancer patients.

Zhu L, Loo WT, Cheng CW, Chow LW. Zhu L, et al. Oncol Rep. 2006 May;15(5):1217-23. Oncol Rep. 2006. PMID: 16596190

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

42 results

Results by year